FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1965374413> ?p ?o ?g. }

• W1965374413 endingPage "886" @default.
• W1965374413 startingPage "878" @default.
• W1965374413 abstract "Aims/hypothesis. Advanced glycation end products are believed to contribute to diabetic microvascular complications by inducing glomerular damage but their role has not been fully clarified. In this study, we explain their central role in the induction of inducible nitric oxide synthase and production of nitric oxide (NO) in streptozotocin-induced diabetic rat glomeruli. Methods. Localization of carboxymethyllysine, which is one of the chemical components of advanced glycation end products, glomerular expression of inducible nitric oxide synthase and urinary excretion and glomerular production of NO2 –/NO3 – were examined at 0, 26, 51, and 52 weeks after the induction of diabetes. Therapeutic effects of aminoguanidine were also examined. Results. Carboxymethyllysine was detected in the mesangial area in glomeruli and it progressively accumulated during 52 weeks of observation. Immunohistochemistry and hybridization studies in situ showed that the number of inducible nitric oxide synthase-positive cells was notably increased in diabetic rat glomeruli at 52 weeks. Further, this augmented expression paralleled intraglomerular expression of TNF-α and NO2 –/NO3 – in diabetic rat glomeruli. Treatment with aminoguanidine reduced the expression of TNF-α, inducible nitric oxide synthase and intraglomerular NO2 –/NO3 – production. It also ameliorated proteinuria in diabetic rats. Conclusion/interpretation. This study showed that carboxymethyllysine possibly enhances the expression of inducible nitric oxide synthase by stimulating the expression of TNF-α in diabetic rat glomeruli. The carboxymethyllysine-cytokine-NO sequence pathway could be one of the major mechanisms in the development of diabetic nephropathy. [Diabetologia (1999) 42: 878–886]" @default.
• W1965374413 created "2016-06-24" @default.
• W1965374413 creator A5007276836 @default.
• W1965374413 creator A5026538420 @default.
• W1965374413 creator A5039655833 @default.
• W1965374413 creator A5070112001 @default.
• W1965374413 creator A5080291594 @default.
• W1965374413 date "1999-06-21" @default.
• W1965374413 modified "2023-10-11" @default.
• W1965374413 title "Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-α and inducible nitric oxide synthase in diabetic rat glomeruli" @default.
• W1965374413 cites W1483156553 @default.
• W1965374413 cites W1502047387 @default.
• W1965374413 cites W1929009802 @default.
• W1965374413 cites W1982607922 @default.
• W1965374413 cites W1994389040 @default.
• W1965374413 cites W2005746857 @default.
• W1965374413 cites W2018920909 @default.
• W1965374413 cites W2037154246 @default.
• W1965374413 cites W2069775587 @default.
• W1965374413 cites W2073132923 @default.
• W1965374413 cites W2079785479 @default.
• W1965374413 cites W2085099786 @default.
• W1965374413 cites W2133299624 @default.
• W1965374413 cites W2145651864 @default.
• W1965374413 cites W2147777431 @default.
• W1965374413 cites W2398759984 @default.
• W1965374413 doi "https://doi.org/10.1007/s001250051241" @default.
• W1965374413 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10440132" @default.
• W1965374413 hasPublicationYear "1999" @default.
• W1965374413 type Work @default.
• W1965374413 sameAs 1965374413 @default.
• W1965374413 citedByCount "145" @default.
• W1965374413 countsByYear W19653744132012 @default.
• W1965374413 countsByYear W19653744132013 @default.
• W1965374413 countsByYear W19653744132014 @default.
• W1965374413 countsByYear W19653744132015 @default.
• W1965374413 countsByYear W19653744132016 @default.
• W1965374413 countsByYear W19653744132017 @default.
• W1965374413 countsByYear W19653744132018 @default.
• W1965374413 countsByYear W19653744132019 @default.
• W1965374413 countsByYear W19653744132020 @default.
• W1965374413 countsByYear W19653744132021 @default.
• W1965374413 countsByYear W19653744132022 @default.
• W1965374413 countsByYear W19653744132023 @default.
• W1965374413 crossrefType "journal-article" @default.
• W1965374413 hasAuthorship W1965374413A5007276836 @default.
• W1965374413 hasAuthorship W1965374413A5026538420 @default.
• W1965374413 hasAuthorship W1965374413A5039655833 @default.
• W1965374413 hasAuthorship W1965374413A5070112001 @default.
• W1965374413 hasAuthorship W1965374413A5080291594 @default.
• W1965374413 hasBestOaLocation W19653744131 @default.
• W1965374413 hasConcept C126322002 @default.
• W1965374413 hasConcept C134018914 @default.
• W1965374413 hasConcept C147990577 @default.
• W1965374413 hasConcept C185592680 @default.
• W1965374413 hasConcept C2777622882 @default.
• W1965374413 hasConcept C2779131090 @default.
• W1965374413 hasConcept C2779280383 @default.
• W1965374413 hasConcept C2779922275 @default.
• W1965374413 hasConcept C2780091579 @default.
• W1965374413 hasConcept C2780368995 @default.
• W1965374413 hasConcept C2781184683 @default.
• W1965374413 hasConcept C3018920779 @default.
• W1965374413 hasConcept C519581460 @default.
• W1965374413 hasConcept C555293320 @default.
• W1965374413 hasConcept C71924100 @default.
• W1965374413 hasConcept C91415057 @default.
• W1965374413 hasConceptScore W1965374413C126322002 @default.
• W1965374413 hasConceptScore W1965374413C134018914 @default.
• W1965374413 hasConceptScore W1965374413C147990577 @default.
• W1965374413 hasConceptScore W1965374413C185592680 @default.
• W1965374413 hasConceptScore W1965374413C2777622882 @default.
• W1965374413 hasConceptScore W1965374413C2779131090 @default.
• W1965374413 hasConceptScore W1965374413C2779280383 @default.
• W1965374413 hasConceptScore W1965374413C2779922275 @default.
• W1965374413 hasConceptScore W1965374413C2780091579 @default.
• W1965374413 hasConceptScore W1965374413C2780368995 @default.
• W1965374413 hasConceptScore W1965374413C2781184683 @default.
• W1965374413 hasConceptScore W1965374413C3018920779 @default.
• W1965374413 hasConceptScore W1965374413C519581460 @default.
• W1965374413 hasConceptScore W1965374413C555293320 @default.
• W1965374413 hasConceptScore W1965374413C71924100 @default.
• W1965374413 hasConceptScore W1965374413C91415057 @default.
• W1965374413 hasIssue "7" @default.
• W1965374413 hasLocation W19653744131 @default.
• W1965374413 hasLocation W19653744132 @default.
• W1965374413 hasOpenAccess W1965374413 @default.
• W1965374413 hasPrimaryLocation W19653744131 @default.
• W1965374413 hasRelatedWork W1667985597 @default.
• W1965374413 hasRelatedWork W1969300951 @default.
• W1965374413 hasRelatedWork W1977852130 @default.
• W1965374413 hasRelatedWork W2046449415 @default.
• W1965374413 hasRelatedWork W2149478838 @default.
• W1965374413 hasRelatedWork W2167859871 @default.
• W1965374413 hasRelatedWork W2286308763 @default.
• W1965374413 hasRelatedWork W2410805971 @default.
• W1965374413 hasRelatedWork W2415678557 @default.
• W1965374413 hasRelatedWork W3032592562 @default.

• next